Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2013, Article ID 908048, 9 pages
http://dx.doi.org/10.1155/2013/908048
Research Article

Treadmill Exercise Training Modulates Hepatic Cholesterol Metabolism and Circulating PCSK9 Concentration in High-Fat-Fed Mice

Department of Exercise and Nutrition Sciences, University at Buffalo, Buffalo, NY 14214, USA

Received 15 March 2013; Accepted 4 June 2013

Academic Editor: Sampath Parthasarathy

Copyright © 2013 Shin Wen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Ronnemaa, J. Marniemi, P. Puukka, and T. Kuusi, “Effects of long-term physical exercise on serum lipids, lipoproteins and lipid metabolizing enzymes in type 2 (non-insulin-dependent) diabetic patients,” Diabetes Research, vol. 7, no. 2, pp. 79–84, 1988. View at Google Scholar · View at Scopus
  2. C. A. Slentz, J. A. Houmard, J. L. Johnson et al., “Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount,” Journal of Applied Physiology, vol. 103, no. 2, pp. 432–442, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Halbert, C. A. Silagy, P. Finucane, R. T. Withers, and P. A. Hamdorf, “Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials,” European Journal of Clinical Nutrition, vol. 53, no. 7, pp. 514–522, 1999. View at Google Scholar · View at Scopus
  4. Z. V. Tran, A. Weltman, G. V. Glass, and D. P. Mood, “The effects of exercise on blood lipids and lipoproteins: a meta-analysis of studies,” Medicine and Science in Sports and Exercise, vol. 15, no. 5, pp. 393–402, 1983. View at Google Scholar · View at Scopus
  5. G. A. Kelley and K. S. Kelley, “Effects of aerobic exercise on lipids and lipoproteins in adults with type 2 diabetes: a meta-analysis of randomized-controlled trials,” Public Health, vol. 121, no. 9, pp. 643–655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Koba, H. Tanaka, C. Maruyama et al., “Physical activity in the Japan population: association with blood lipid levels and effects in reducing cardiovascular and all-cause mortality,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 10, pp. 833–845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. W. E. Kraus, J. A. Houmard, B. D. Duscha et al., “Effects of the amount and intensity of exercise on plasma lipoproteins,” The New England Journal of Medicine, vol. 347, no. 19, pp. 1483–1492, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Huffman, V. H. Hawk, S. T. Henes et al., “Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in studies of a targeted risk reduction intervention through defined exercise I,” The American Heart Journal, vol. 164, no. 1, pp. 117–124, 2012. View at Publisher · View at Google Scholar
  9. E. S. Ficker, R. C. Maranhão, A. P. M. Chacra et al., “Exercise training accelerates the removal from plasma of LDL-like nanoemulsion in moderately hypercholesterolemic subjects,” Atherosclerosis, vol. 212, no. 1, pp. 230–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. W. E. Kraus and C. A. Slentz, “Exercise training, lipid regulation, and insulin action: a tangled web of cause and effect,” Obesity, vol. 17, supplement 3, pp. S21–S26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. D. Marais, “Familial hypercholesterolaemia,” Clinical Biochemist Reviews, vol. 25, pp. 49–68, 2004. View at Google Scholar
  12. M. S. Brown and J. L. Goldstein, “The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor,” Cell, vol. 89, no. 3, pp. 331–340, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. N. G. Seidah and A. Prat, “The biology and therapeutic targeting of the proprotein convertases,” Nature Reviews Drug Discovery, vol. 11, no. 5, pp. 367–383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Farnier, “The role of proprotein convertase subtilisin/kexin type 9 in hyperlipidemia: focus on therapeutic implications,” The American Journal of Cardiovascular Drugs, vol. 11, no. 3, pp. 145–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Poirier, G. Mayer, V. Poupon et al., “Dissection of the endogenous cellular pathways of PCSK9-induced low density Lipoprotein receptor degradation. Evidence for an intracellular route,” The Journal of Biological Chemistry, vol. 284, no. 42, pp. 28856–28864, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. J. Hyun, H. Lee, K. Kim, Y. Kim, D. Yoon, and W. P. Sahng, “Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2,” Journal of Lipid Research, vol. 49, no. 2, pp. 399–409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. C. G. J. Brouwers and M. M. J. van Greevenbroek, “Lipid Metabolism: the significance of plasma proprotein convertase subtilisin kexin type 9 in the elucidation of complex lipid disorders,” Current Opinion in Lipidology, vol. 22, no. 4, pp. 317–318, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Richard, P. Couture, S. Desroches et al., “Effect of the Mediterranean diet with and without weight loss on surrogate markers of cholesterol homeostasis in men with the metabolic syndrome,” The British Journal of Nutrition, vol. 107, no. 5, pp. 705–711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. C. Chong, M. A. Dollah, P. P. Chong, and A. Maha, “Phaleria macrocarpa (Scheff.) Boerl fruit aqueous extract enhances LDL receptor and PCSK9 expression in vivo and in vitro,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 817–827, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Cariou, C. Langhi, M. Le Bras et al., “Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets,” Nutrition and Metabolism, vol. 10, no. 1, article 4, 2013. View at Publisher · View at Google Scholar
  21. F. Beppu, M. Hosokawa, Y. Niwano, and K. Miyashita, “Effects of dietary fucoxanthin on cholesterol metabolism in diabetic/obese KK-A(y) mice,” Lipids in Health and Disease, vol. 11, article 112, 2012. View at Google Scholar
  22. E. A. Stein, D. Gipe, J. Bergeron et al., “Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial,” The Lancet, vol. 380, no. 9836, pp. 29–36, 2012. View at Publisher · View at Google Scholar
  23. M. Frank-Kamenetsky, A. Grefhorst, N. N. Anderson et al., “Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 33, pp. 11915–11920, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. V. L. Billat, E. Mouisel, N. Roblot, and J. Melki, “Inter- and intrastrain variation in mouse critical running speed,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1258–1263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. T. C. Rideout, S. V. Harding, and P. J. H. Jones, “Consumption of plant sterols reduces plasma and hepatic triglycerides and modulates the expression of lipid regulatory genes and de novo lipogenesis in C57BL/6J mice,” Molecular Nutrition and Food Research, vol. 54, supplement 1, pp. S7–S13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S. V. Harding, T. C. Rideout, and P. J. H. Jones, “Hepatic nuclear sterol regulatory binding element protein 2 abundance is decreased and that of ABCG5 increased in male hamsters fed plant sterols,” Journal of Nutrition, vol. 140, no. 7, pp. 1249–1254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. L. Williamson, N. Kubica, S. R. Kimball, and L. S. Jefferson, “Exercise-induced alterations in extracellular signal-regulated kinase 1/2 and mammalian target of rapamycin (mTOR) signalling to regulatory mechanisms of mRNA translation in mouse muscle,” Journal of Physiology, vol. 573, no. 2, pp. 497–510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Langheim, L. Yu, K. von Bergmann et al., “ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile,” Journal of Lipid Research, vol. 46, no. 8, pp. 1732–1738, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. C. Rideout, Z. Yuan, M. Bakovic et al., “Guar gum consumption increases hepatic nuclear SREBP2 and LDL receptor expression in pigs fed an atherogenic diet,” Journal of Nutrition, vol. 137, no. 3, pp. 568–572, 2007. View at Google Scholar · View at Scopus
  30. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, no. 9, article e45, 2001. View at Google Scholar · View at Scopus
  31. P. Costet, B. Cariou, G. Lambert et al., “Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c,” The Journal of Biological Chemistry, vol. 281, no. 10, pp. 6211–6218, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. E. P. Ratliff, A. Gutierrez, and R. A. Davis, “Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia,” Journal of Lipid Research, vol. 47, no. 7, pp. 1513–1520, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Feng, Y. Wang, Y. Mei et al., “Stearoyl-CoA desaturase 1 deficiency protects mice from immune-mediated liver injury,” Laboratory Investigation, vol. 89, no. 2, pp. 222–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Meissner, E. Lombardo, R. Havinga, U. J. F. Tietge, F. Kuipers, and A. K. Groen, “Voluntary wheel running increases bile acid as well as cholesterol excretion and decreases atherosclerosis in hypercholesterolemic mice,” Atherosclerosis, vol. 218, no. 2, pp. 323–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Napoli, S. Williams-Ignarro, F. de Nigris et al., “Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 23, pp. 8797–8802, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Napoli, S. Williams-Ignarro, F. de Nigris et al., “Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10479–10484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. M. V. Heeren, L. E. de Sousa, C. Mostarda et al., “Exercise improves cardiovascular control in a model of dislipidemia and menopause,” Maturitas, vol. 62, no. 2, pp. 200–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Moien-Afshari, S. Ghosh, M. Khazaei, T. J. Kieffer, R. W. Brownsey, and I. Laher, “Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice,” Diabetologia, vol. 51, no. 7, pp. 1327–1337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Haskell-Luevano, J. W. Schaub, A. Andreasen et al., “Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse,” FASEB Journal, vol. 23, no. 2, pp. 642–655, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. F. F. Donatto, R. X. Neves, F. O. Rosa et al., “Resistance exercise modulates lipid plasma profile and cytokine content in the adipose tissue of tumour-bearing rats,” Cytokine, vol. 61, no. 2, pp. 426–432, 2013. View at Publisher · View at Google Scholar
  41. N. Pattyn, V. A. Cornelissen, S. R. Eshghi, and L. Vanhees, “The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials,” Sports Medicine, vol. 43, no. 2, pp. 121–133, 2013. View at Publisher · View at Google Scholar
  42. B. G. Teodoro, A. J. Natali, S. A. Fernandes et al., “Improvements of atherosclerosis and hepatic oxidative stress are independent of exercise intensity in LDLr(-/-) mice,” Journal of Atherosclerosis and Thrombosis, vol. 19, no. 10, pp. 904–911, 2012. View at Google Scholar
  43. M. Meissner, N. Nijstad, F. Kuipers, and U. J. F. Tietge, “Voluntary exercise increases cholesterol efflux but not macrophage reverse cholesterol transport in vivo in mice,” Nutrition and Metabolism, vol. 7, article 54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. F. S. Lira, F. L. Tavares, A. S. Yamashita et al., “Effect of endurance training upon lipid metabolism in the liver of cachectic tumour-bearing rats,” Cell Biochemistry and Function, vol. 26, no. 6, pp. 701–708, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Yin, E. Carballo-Jane, D. G. McLaren et al., “Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia,” Journal of Lipid Research, vol. 53, no. 1, pp. 51–65, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. R. Turk and M. H. Laughlin, “Physical activity and atherosclerosis: Which animal model?” Canadian Journal of Applied Physiology, vol. 29, no. 5, pp. 657–683, 2004. View at Google Scholar · View at Scopus
  47. K. R. Wilund, L. A. Feeney, E. J. Tomayko, H. R. Chung, and K. Kim, “Endurance exercise training reduces gallstone development in mice,” Journal of Applied Physiology, vol. 104, no. 3, pp. 761–765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Wei, M. Penumetcha, N. Santanam, Y. Liu, M. Garelnabi, and S. Parthasarathy, “Exercise might favor reverse cholesterol transport and lipoprotein clearance: potential mechanism for its anti-atherosclerotic effects,” Biochimica et Biophysica Acta, vol. 1723, no. 1–3, pp. 124–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. D. J. Mahoney, A. Safdar, G. Parise et al., “Gene expression profiling in human skeletal muscle during recovery from eccentric exercise,” The American Journal of Physiology, vol. 294, no. 6, pp. R1901–R1910, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Kosenko, M. Golder, G. Leblond, W. Weng, and T. A. Lagace, “Low-density lipoprotein binds to proprotein convertase subtilisin/kexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated LDL receptor degradation,” The Journal of Biological Chemistry, vol. 288, no. 12, pp. 8279–8288, 2013. View at Publisher · View at Google Scholar
  51. R. J. Schmidt, T. P. Beyer, W. R. Bensch et al., “Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo,” Biochemical and Biophysical Research Communications, vol. 370, no. 4, pp. 634–640, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Roubtsova, M. N. Munkonda, Z. Awan et al., “Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 4, pp. 785–791, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Persson, C. Gälman, B. Angelin, and M. Rudling, “Importance of proprotein convertase subtilisin/kexin type 9 in the hormonal and dietary regulation of rat liver low-density lipoprotein receptors,” Endocrinology, vol. 150, no. 3, pp. 1140–1146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Melone, L. Wilsie, O. Palyha, A. Strack, and S. Rashid, “Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9,” Journal of the American College of Cardiology, vol. 59, no. 19, pp. 1697–1705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. S. H. Jung, H. S. Park, K. Kim et al., “Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss,” Journal of Nutritional Biochemistry, vol. 19, no. 6, pp. 371–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. N. P. Kadoglou, D. Perrea, F. Iliadis, N. Angelopoulou, C. Liapis, and M. Alevizos, “Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes,” Diabetes Care, vol. 30, no. 3, pp. 719–721, 2007. View at Publisher · View at Google Scholar · View at Scopus